Chapter 19: Antiseizure Drugs & Epilepsy Treatment

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

I'm going to be honest with you right out of the gate.

Today's topic usually scares people.

It definitely scares nursing students and frankly, it scares a lot of patients when they first hear the diagnosis.

It does.

It absolutely does.

It carries a heavy weight.

We are diving into the human brain's electrical system, specifically

what happens when that system goes haywire.

We are talking about chapter 19 of pharmacology,

a patient -centered nursing process approach.

The title is pretty dry, anti -seizure drugs, but the content is anything but.

Oh, not at all.

This is about storms in the brain, drugs that have been around since the 1930s and the razor thin line between stopping a seizure and well, stopping a heart.

And that is not an exaggeration, not in the slightest.

This chapter covers some of the most high stakes medications in the entire pharmacologic toolkit.

We aren't just talking about popping a Tylenol for a headache.

We are talking about altering the fundamental way neurons fire.

Exactly.

And for everyone listening, whether you're prepping for the NCLEX, you're a practicing nurse needing a refresher, or maybe you're just someone who wants to understand how we medically control chaos.

Our mission today is very, very specific.

We are going to demystify epilepsy and the drugs used to treat it.

But here's the constraint.

We are strictly sticking to the text in chapter 19.

No Wikipedia rabbit holes.

No, my aunt had this anecdote.

Unless they align perfectly with the text, we are decoding the source material.

Which is so crucial because this text is the standard.

It really builds that foundation.

If you can get your head around the physiology and the prototype drugs here, you can handle any curve ball a patient or an exam question throws at you.

So grab your coffee or your highlighter, or just turn up the volume.

Let's map this out.

We're going to start by looking at the enemy, the seizure itself, what is happening physiologically.

Then we're going to look at the weapons, the pharmacophysiology.

You know, how do we tell a neuron to just chill out?

And from there, we are going to spend a serious chunk of our time on the heavy hitter, the drug that really defines this entire chapter, Finitoin.

I feel like we need a dramatic sound effect every time we say Finitoin.

It's that important.

It is the prototype.

I mean, if you don't understand Finitoin, you just don't understand this chapter.

It's that simple.

Okay.

From there, we'll tour the other drug classes, talk about the really scary stuff like status epilepticus and pregnancy complications, and then wrap it all up with the nursing process, which is basically how to keep your patient alive while on these drugs.

Safety.

Safety is the red thread running through this entire discussion.

You'll hear us come back to it again and again.

All right.

Let's get into the wiring.

The text opens with some really staggering numbers.

It says approximately 3 .4 million people in the United States have active epilepsy.

That is not a small niche group.

No, it's a massive population, a huge population.

And the text defines epilepsy in a very specific way.

It is a chronic seizure disorder.

But the key, the real key, is the mechanism.

It results from abnormal electric discharges from the cerebral neurons.

I love the imagery the text implies here.

It's basically an electrical storm in the brain.

That's the best analogy.

It really is.

Under normal conditions, your brain is a well -conducted orchestra.

Everything fires when it's supposed to.

Everything is in harmony.

In epilepsy, you have a section of the orchestra, or sometimes the whole orchestra, that decides to play as loud and as fast as possible all at once.

This is chaos.

Total chaos.

And it's characterized by a loss or disturbance of consciousness, and usually involuntary uncontrolled movements.

But why?

What causes the conductor to just lose control like that?

Well, the text boils it down to a disruption in the electrical functioning.

It's a seesaw.

On one side, you have excitation.

Those are the go signals.

On the other side, you have inhibition, stop signals.

A seizure happens when there's an imbalance.

So too much gas or not enough breaks.

That's a perfect way to put it.

You might have an excessive amount of excitation discharges.

The text points to a few culprits here.

It could be a defect in the neuronal membrane itself, making it leaky or unstable.

Or, and this is the big one for pharmacology, it could be related to sodium influx.

The sodium influx.

Okay, I have a feeling we're going to hear that word sodium a lot today.

A lot.

A whole lot.

When sodium rushes into a cell, the neuron fires.

It's the trigger.

If too much sodium rushes in or it rushes in too often, you get this rapid repetitive firing.

That's your too much gas scenario.

Okay, that makes sense.

So what about the not enough breaks scenario?

That involves GABA.

Gamma immunobutyric acid.

GABA is the brain's primary inhibitory neurotransmitter.

It's the chill pill of the central nervous system.

Its job is to say, okay, calm down.

If you have a decrease in GABA activity, the brain can't calm itself down.

The excitation just runs wild.

Okay, so we have the mechanics of the storm, but what kicks it off?

The text separates causes into two big buckets, primary and secondary.

And this distinction is absolutely vital for a nurse to understand.

Primary, which the text says accounts for about 75 % of seizure cases, is idiopathic.

Which is fancy doctor speak for, we have no idea.

Essentially, yes, means of unknown cause.

We can't point to a tumor or a specific injury.

We can't find a direct reason.

It just is.

But the remaining 25 % are secondary.

These are secondary to something else.

Like what?

The text lists things like brain trauma, anoxia, which is a lack of oxygen to the brain, and infection like meningitis or cerebral vascular accident, like a stroke.

Something happened to the brain tissue to make it irritable.

Now, here's a part of the text that I think is so, so crucial for nurses to grasp.

Not every single seizure means the patient has epilepsy.

This is a huge aha moment when you're studying.

A really big one.

The text lists several isolated causes of seizures.

Fever, especially in kids, hypoglycemia, alopecia sugar, electrolyte imbalances, metabolic imbalances like acidosis or alkalosis, and even alcohol or drug withdrawal.

So if a patient comes into the ER seizing and their blood sugar is a 30, or their sodium is critically low.

You don't jump to diagnosing them with epilepsy.

You don't start them on lifelong feinty -toin.

You treat the hypoglycemia.

You give them sugar.

You fix the hyponatremia.

The text explicitly states,

if you correct the underlying condition, the seizures stop.

And that's fundamentally different from the chronic disorder of epilepsy.

Fundamentally.

Yeah.

That usually requires lifelong management.

This is a temporary reversible problem.

Speaking of lifelong management, we need to understand what we are managing.

The international classification of seizures, table 19 .1 in the text.

This breaks it down into two main categories,

generalized and partial.

Think of generalized seizures as involving the whole brain.

Both hemispheres are misfiring at the same time.

It's a global event.

And the poster child for this is the tonic -clonic seizure, the one everyone pictures.

Right.

We used to call this grand mal, and you'll definitely still hear that term out in clinicals.

But tonic -clonic is the more descriptive term, and it describes exactly what you see.

Walk us through the phases, because the text is very specific about the timing and what's happening.

Okay.

So first is the tonic phase.

Tonic means tone or tension.

The skeletal muscles contract tightly.

The patient goes rigid, like a board.

The text says this lasts about three to five seconds.

That sounds really short, but I imagine if you're watching a patient go board stiff, five seconds is a very long time.

It feels like an eternity for the patient and for the nurse.

Then immediately following that comes the clonic phase.

This is the dysrhythmic muscular contraction, the jerking.

The arms and legs are thrashing.

And this lasts much longer, about two to four minutes.

And that's the part where there's a huge physical danger, right?

They can bang their head.

They can bite their tongue.

Exactly.

This is where patient safety becomes paramount.

But generalized seizures aren't just the violent shaking ones.

The text also describes absence seizures.

These used to be called pitimel.

And these are the ones that are so easy to miss, especially in kids.

Very easy.

It involves a brief loss of consciousness.

And the text says it's usually less than 10 seconds.

It's most common in children.

To a teacher, it might just look like the kid is daydreaming or staring into space for a moment.

But physiologically, their entire brain is having a generalized seizure.

Wow.

Then we have myoclonic, which the text says are isolated jerks, and atonic.

Atonic sounds particularly hazardous to me.

It is.

Atonic means lack of tone.

The text calls it a head drop.

The muscles just give out instantly.

If the patient is standing, they collapse.

It's a massive, massive fall risk.

They often have to wear helmets.

Okay.

So those are generalized, both sides of the brain, all at once.

What about partial seizures?

Partial seizures involve only one hemisphere.

The storm is localized to one part of the brain.

And we split these into two subtypes, simple and complex.

Simple meaning?

Well, simple.

Simple meaning no loss of consciousness.

The patient is awake and aware of what's happening.

But they might experience motor symptoms.

The book gives the example of a Jacksonian seizure, where the shaking might start in the hand and then spread up the arm.

Or they might have sensory symptoms.

The text says they might have hallucinations.

Hallucinate, like seeing things that aren't there.

Seeing things, hearing things, even smelling things that aren't there.

Or they might have autonomic responses, sudden flushing, sweating, a racing heart.

But the key is they are aware.

They can tell you about it afterward.

Okay.

So contrast that with complex partial seizures.

In complex seizures, there is a loss of consciousness, or at least an impairment of consciousness.

The patient won't remember the events.

There will be a memory gap.

And this is where you see something called automatisms.

Automatisms.

That's a key vocabulary word from the chapter.

Definitely.

It refers to these repetitive, non -purposeful behaviors.

The text lists things like lip smacking, chewing motions, or aimlessly pulling at their clothing.

The patient is physically doing it, but they aren't there.

They're on autopilot.

It's fascinating and also terrifying and obviously very complex.

So we have this huge array of electrical malfunctions.

Now we need to figure out how to fix it.

Let's move to section two.

Pharmacophysiology.

How do these drugs actually work on a cellular level?

Okay.

This is where we go right back to that seesaw.

Excitation versus inhibition.

The text outlines three specific mechanisms of action that these anti -seizure drugs use to try and restore order in the brain.

All right.

What's mechanism number one?

Suppressing sodium influx.

Okay.

Let's visualize this.

Help me see what's happening.

Okay.

Imagine the neuron is a nightclub.

And sodium ions are the people trying to rush in the door to get the party started.

When enough sodium gets inside, the neuron fires.

The party starts.

The music is blasting.

And in a seizure, the door is just wide open and everyone is stampeding in nonstop.

Exactly.

So drugs like finny toine, carbamazepine, and valproic acid, they act like a bouncer, a very specific kind of bouncer who holds the door shut just a little bit longer than usual.

Specifically, the text says they bind to the sodium channel when it's in an inactivated state.

They prolong that inactivation.

They keep the door locked for an extra millisecond.

And that tiny extra millisecond actually matters.

It matters immensely because it prevents the neuron from being able to fire repetitively at a super high speed.

It forces the brain to take a breath between signals.

It stops the stampede.

Okay, that makes perfect sense.

What's mechanism number two?

Suppressing calcium influx.

Calcium also plays a role in generating electric current in the neuron, specifically at something called the T -type calcium channel.

Drugs like valproic acid and ethosuximide block these channels.

It's a very similar concept.

You're stopping the flow of positive ions that cause the excitation.

And mechanism number three.

This has to be the breaks one.

This is the breaks one.

Enhancing GABA.

Remember, GABA is the great inhibitor.

So drugs like barbiturates and benzodiazepines, they don't pretend to be GABA, but they bind to GABA receptors and they help GABA do its job better.

They make the breaks more powerful.

So they're like a break booster.

Exactly.

They essentially slam on the breaks, the increased inhibition throughout the central nervous system.

So we either block the gas, which is the sodium and calcium, or we boost the breaks, which is GABA.

That is the pharmacological strategy in a nutshell.

And the goal, according to the text, is to stabilize the nerve cell membranes and suppress the abnormal impulses.

But, and I cannot stress this point enough, these drugs do not cure the disorder.

That's such a hard reality for patients to accept.

It is.

It truly is.

The text notes that success involves controlling seizures in approximately 70 % of patients.

It's about management.

It's about suppression.

It is not a cure.

Which leads us nicely into the general concepts in section three.

The text uses a few terms interchangeably.

Anti -seizure drugs, anti -convulsants, anti -epileptic drugs, or AEDs.

But they all share a classification,

CNS depressants.

Which, when you think about it, follows logically.

If your entire goal is to dampen the electrical activity of the brain, you are, by definition, depressing the central nervous system.

This has huge implications for everything.

Alertness, breathing, coordination, you name it.

And for most patients, this treatment is for life.

Usually, yes.

However, the text does offer a little glimmer of hope.

It says a healthcare provider might consider discontinuing the medication if, and this is a big if, there have been no seizures for three to five years.

But that's a risky game to play.

You're taking away the safety net.

It's a very calculated risk.

And it's always, always done as a slow taper over months.

Never a cold turkey stop.

And let's talk about dosing.

This isn't like dosing an antibiotic where you just check the weight and go.

The text highlights that age creates massive variables in how these drugs work.

Huge variables.

Let's look at the extremes of age.

The text groups together newborns, people with liver disease, and older adults.

They generally require a lower dosage.

Okay.

And why is that?

It all comes down to metabolism.

These drugs are primarily metabolized by the liver.

In newborns, the liver isn't fully mature.

It's not up to speed yet.

In older adults, or those with liver disease, the liver is, well, tired.

It works much slower.

Yeah.

If the liver doesn't break down the drug efficiently, the drug stays in the blood.

It accumulates.

So a normal dose very quickly becomes a toxic dose simply because the body isn't clearing it.

Exactly.

And then on the complete flip side, you have children, not newborns, but say school -aged kids.

Their metabolism is often in overdrive.

They burn through the drug much faster than adults do.

So counterintuitively, they might need a higher relative dosage to maintain those therapeutic levels.

This brings us to the absolute holy grail of this chapter.

Therapeutic monitoring.

We are going to talk about the therapeutic range.

This is probably the most important concept for patient safety in the entire chapter.

The therapeutic range is that sweet spot, that perfect concentration in the blood, where the drug is strong enough to control seizures, but not so strong that it starts to poison the patient.

It's the Goldilocks zone.

Not too much, not too little.

It is.

And for some drugs, that zone is pretty wide and forgiving.

For others, it is terrifyingly narrow.

Which brings us to the main event, section four, hydantones.

Specifically, the prototype drug, phenytoin.

Ah, phenytoin.

This drug was discovered in 1938, and it is still a front -line drug today.

That tells you two things.

One, it works incredibly well at what it does.

And two, we still haven't found anything that completely replaces it, despite all of its issues.

And it has issues.

It's a very high maintenance drug, isn't it?

It is.

It works by inhibiting sodium influx.

It's that bouncer holding the door.

But let's look at the pharmacokinetics, because this is where the trouble starts.

Absorption is slow,

but the protein binding,

we need to stop and really, really unpack protein binding.

Okay.

The text says it is highly protein -bound, specifically 90 % to 95%.

Explain this to me like I'm a tired nursing student at the end of a long clinical day.

Okay.

Imagine your bloodstream is a highway.

And the drug molecules, the phenytoin molecules, are passengers.

But they can't just walk down the highway.

They have to hitch a ride on a bus.

And in the blood, the main bus is a protein called albumin.

Okay.

So the drug is on the bus, on the albumin.

Right.

And here's the critical part.

When the drug is sitting on the bus, when it's bound to the protein,

it is inactive.

It can't do anything.

It can't get off the highway and go into the brain tissues to work.

It's just riding along for the ride.

Only the passengers that get off the bus, the free drug, can actually do the work of stopping seizures.

So if phenytoin is 95 % protein -bound...

That means at any given time, 95 % of the drug in your system is stuck on the bus doing nothing.

Only a tiny 5 % is actually free and active.

Okay.

That seems inefficient, but I guess the body has it figured out.

So what's the problem?

The problem arises when you run out of buses.

Imagine an older adult or someone who is malnourished or has liver disease.

Their body doesn't make as much protein.

They have low albumin levels.

They have fewer buses on the highway.

So there are fewer seats available for the drug.

Exactly.

So instead of 95 % of the drug finding a seat on the bus, maybe only 80 % can find a seat.

So now you have 20 % of the drug wandering around free and active instead of the expected 5%.

Yeah.

You have quadrupled the amount of active drug in the system, even though the pill dosage was exactly the same.

So low protein levels equals a massive risk for high toxicity.

Precisely.

That is why nurses have to, have to, have to check those albumin levels before giving this drug.

The text also mentions that the half -life is weirdly variable.

It's highly variable.

The average is about 22 hours, but the text gives a range of 7 to 60 hours.

This makes achieving and maintaining a steady state in the blood incredibly difficult.

Let's talk about administration.

If the protein binding didn't scare you, IV phenytoin definitely will.

IV phenytoin is not a drug you administer casually.

It's not like hanging a bag of saline.

The text has a list of do -nots that is much longer than the list of do's.

First rule right off the bat.

No, I am.

Never, ever give it intramuscularly.

The absorption is erratic and unpredictable and it's extremely irritating to the tissue.

Just don't do it.

So IV only, but there are very specific rules.

Serious rules.

First, let's talk about the lime.

You want a large vein, ideally a central line or a PICC line.

If you absolutely have to use a peripheral IV, it better be a good big one like in the anticubital space, not a little hand vein.

And the fluid, what do you mix it with?

Saline only, 8 .9 % sodium chloride, period.

Why not dextrose?

I mean, we hang dextrose solutions all the time.

Because if you mix phenytoin with dextrose, it precipitates.

That means it turns from a liquid into a solid.

It forms tiny sharp crystals inside the IV tubing.

So you're basically pumping sand into the patient's vein.

You are.

You're creating an embolus of crystals.

It is absolutely catastrophic.

So the procedure has to be flush with saline, give the drug, flush again with saline.

Nothing else touches that line.

And there's a filter involved?

Yes, you must use an inline filter.

It's a special filter in the tubing designed to catch any of those microscopic crystals that might form anyway.

It's the last line of defense.

OK, and the speed, you can't just slam it in.

Absolutely not.

This might be the most critical rule of all.

The text is very specific.

For an adult, the maximum rate is 50 milligrams per minute.

For an older adult, it is even slower, 25 milligrams per minute.

You have to use an IV pump programmed precisely.

What happens if I get impatient or there's an emergency and I push it faster than that?

You will crash the patient.

The text says it causes severe hypotension.

Their blood pressure will plummet and life -threatening cardiac dysrhythmias.

You can put them into ventricular fibrillation.

You can literally stop their heart by pushing this seizure med too fast.

And then there is the local reaction at the IV site.

The text has this terrifying name for it.

Purple Glove Syndrome.

It is a nightmare scenario, even if you do everything right with the rate in dilution.

But especially if the IV infiltrates and the drug leaks into the tissue,

phenytoin is incredibly caustic.

The hand and arm become swollen, intensely painful, and turn a dark, dusky purple color.

It sounds like a really bad bruise, but it's obviously much worse.

So much worse.

It can lead to tissue necrosis, the actual death of the tissue.

The text uses the word sloughing, which is a polite medical term for the skin just falling off.

It can be so severe that it requires amputation of the limb.

Amputation from an IV drug.

That is incredibly sobering.

It is.

That's why many hospitals have moved to using phosphenytoin, which is a prodrug that's much safer for IV use.

But phenytoin is still the prototype.

It's still widely used.

So every nurse has to respect the Purple Glove.

Okay.

Let's assume we got the drug in safely.

Now the patient has to live with it.

What are the common side effects?

There's a whole spectrum.

Some are annoying and cosmetic, some are metabolic, and some are just flat out deadly.

Let's start with the cosmetic one because it's so unique to phenytoin.

Gingival hyperplasia.

This is the overgrowth of the gum tissue.

The gums become red, tender, they bleed easily, and they literally start to grow down over the teeth.

It can become so pronounced that it affects eating, speech, and of course, self -esteem.

That's not just cosmetic.

That really affects a person's quality of life.

It does.

And we'll talk about how to manage that in the patient teething section.

Other sort of milder side effects include nystagmus, which is that rhythmic back and forth movement of the eyes, as well as headache and nausea.

What about metabolic effects?

Hyperglycemia.

Phenytoin actually inhibits the release of insulin from the pancreas.

So if your patient is diabetic, their blood sugar is going to go up.

You have to watch that very, very closely.

And the life -threatening ones.

Well, we already mentioned the cardiac issues if it's pushed too fast.

But with long -term use, we're always on the lookout for blood dyscrasias.

Define that term for us.

It just means bad blood.

Things like thrombocytopenia, which is low platelets, meaning a high risk for bleeding,

or leukopenia, which is low white blood cells, meaning a high risk for infection.

The most severe is granulocytosis, where the bone marrow just stops making cells altogether.

And we can't forget Stevens -Johnson syndrome.

SJS.

This severe blistering rash that can cover the whole body.

Any patient on phenytoin who develops a rash, it is a medical emergency until proven otherwise.

You stop the drug, you call the doctor.

And through all of this, we are monitoring that therapeutic range.

This is the number to tattoo on your brain.

10 to 20 micrograms per milliliter.

10 to 20.

And that is not a suggestion.

It is a hard and fast rule.

If you are 8, the patient is at risk for seizures.

If you are at 25, the patient is toxic.

It is a razor -thin window.

Let's talk about interactions quickly.

Phenytoin seems like a bully on the pharmacologic playground.

It really is.

Because it is so highly protein -bound, it loves to compete with other drugs for those seats on the albumin bus.

Take anticoagulants like warfarin or even aspirin.

Phenytoin will literally kick them off the protein bus.

And so now you have all this free -floating blood thinner in the system.

And your patient's INR goes through the roof and they can bleed out.

It also interacts with antacids and calcium.

They block its absorption.

And the text even points out herbs.

Ginkgo can decrease the effectiveness of phenytoin.

Okay, that's Phenytoin, the king, a very demanding king.

But there are other players in the kingdom.

Let's move to section 5, other major drug classes.

Starting with the barbiturates, phenobarbital.

Phenobarbital is the old guard.

It's been around forever.

It works by enhancing GAVA activity.

It's used for tonic, clonic, partial, and also for status epilepticus.

And its therapeutic range.

It's a little wider than phenytoin, which is nice.

It's 10 to 40 mL CGML.

Still needs to be monitored, but there's more wiggle room.

What's the major downside?

Sedation.

I mean, profound sedation.

It makes people incredibly sleepy.

And tolerance develops over time.

The body gets used to it.

So you need more of the drug to get the same seizure control.

And like all of these, you must, must, must discontinue it gradually to avoid rebound seizures.

Next up, succinamides.

The prototype is ethosuximide.

This is a specialist drug.

The text is very clear that it is the drug of choice for one specific type of seizure.

Absent seizures.

Just absent seizures?

Primarily, yes.

It's not a broad spectrum drug.

It works by decreasing calcium influx.

Its therapeutic range is much higher.

40 to 100 mL CGML.

What are the risks with this one?

A very similar theme.

Blood dyscrasias are a concern.

But it also has rare but serious links to causing systemic lupus erythematosus, SLE, and psychosis.

Then we have the benzodiazepines.

We usually think of these drugs for anxiety, like Xanax or erbalium.

Right, but they are incredibly powerful anticonvulsants because they are fantastic at boosting GABA.

The text mentions clonazepam is used for absence or myoclonic seizures.

But the big problem with long -term use is tolerance.

The text says it can stop working effectively after about six months, so the dosing has to be constantly adjusted.

And what about diazepam?

Valium.

Diazepam, specifically IV diazepam, is the hero drug for acute attacks.

It is the first line of defense, the drug of choice, for status epilepticus.

But, and this is a critical but, it has a very short duration of action.

So it works really fast, but it also quits really fast?

Exactly.

It stops the seizure now, but in 20 or 30 minutes the patient is completely unprotected.

That's why you always, always follow it up with a long -acting drug like phenytoin.

Okay, iministal beans.

Carbamazepine.

That's a mouthful.

Carbamazepine is used for tonic -clonic and partial seizures.

But it has a double life.

It's also used for psychiatric disorders like bipolar disorder and for nerve pain like trigeminal neuralgia.

With its range.

Pretty narrow again.

Four to 12 millisiege ML.

And this one has a very specific food interaction that is famous in pharmacology.

You see it on every exam.

The grapefruit juice effect.

For some reason, grapefruit juice contains a compound that inhibits the liver enzymes that break down carbamazepine.

So if you drink the juice, the drug can't get metabolized and it just builds up in your system.

Maybe you get toxic very quickly.

Patients on carbamazepine simply cannot have grapefruit or grapefruit juice.

It's an absolute contraindication.

Lastly, in this main section,

valproic acid or valpro.

This is a great broad spectrum drug.

It's used for tonic -clonic, absence and partial seizures.

It kind of does it all.

Its range is 50 to 100 millisiege ML.

But it has a specific organ that it really hates.

The liver.

Hepatotoxicity is a major, major concern with valproic acid.

The text has a safety alert and explicitly says it is not given to children under two years old for this reason.

And for any patient on it, you have to monitor their liver enzymes, their AST and ALT constantly.

Okay, so we've met the major players.

Now let's put them in some real -world contexts.

Section six.

Anti -seizure drugs in selected situations.

First up, pregnancy.

This feels like an absolutely impossible choice for a mother to have to make.

It's a profound ethical and medical dilemma.

Here's the brutal reality.

Seizures are dangerous to the fetus.

Hypoxia, that lack of oxygen during a maternal seizure, can cause brain damage or even death to the baby.

But the very drugs we use to stop the seizures are teratogenic.

They cause birth defects.

They do.

The text specifically links phenytoin and carbamazepine to cardiac defects in cleft lip or palate.

And valproic acid is known to cause major congenital malformations, including neural tube defects like spina bifida.

And the text also mentions a statistic that the incidence of these defects increases when multiple drugs are used.

Which just makes sense.

More chemicals, more risk.

But often stopping the drug isn't an option because the risk from the seizures is even worse.

So it's a constant balancing act.

There's also a very specific issue mentioned with vitamin K.

Yes, this is important.

Phenytoin, carbamazepine, and phenobarbital all act as inhibitors of vitamin K.

And vitamin K is essential for blood clotting.

So the infant is born with a higher risk of hemorrhage.

Correct.

A serious bleeding risk.

To mitigate this, the standard of care is that pregnant women on these AEDs are given vitamin K supplements during the last few weeks of pregnancy.

And the infant receives a shot of vitamin K immediately after birth.

And what about folate?

These drugs are notorious for sucking the folate right out of the body.

And we know that folate deficiency is a direct cause of neural tube defects.

So any woman of childbearing age on these drugs needs to be on high dose folic acid supplementation.

It's mandatory.

Let's shift from pregnancy to children.

Fibril seizures.

This terrifies parents.

A young child, usually between three months and five years old, spikes a high fever from a simple virus and suddenly has a tonic -clonic seizure.

Do we put that child on phenytoin for life?

Generally, no.

The text is clear that prophylactic treatment with long -term drugs is usually not done unless the child is very high risk or has had multiple complex febrile seizures.

For most, we just treat the fever aggressively.

Sometimes prophylactic phenobarbital or diazepam is used during a febrile illness.

But remember, nalproic acid is avoided in the little ones because of that liver toxicity.

Now let's talk about the big emergency scenario, section six, status epilepticus.

This is the co -blue of neurology, a true medical emergency.

Define it for us based on the text.

It is a continuous seizure state.

Or it's a series of seizures that follow one another without the patient recovering consciousness in between.

The brain is stuck in the on position.

And why is it so dangerous?

Why is it a top priority?

Because the brain is literally frying itself.

It's using up glucose and oxygen at an incredible rate faster than the body can possibly supply it.

Neurons begin to die from the metabolic stress.

The patient stops breathing properly.

Respiratory acidosis sets in.

If you don't stop it, the patient suffers permanent brain damage or dies.

The text outlines a very specific treatment protocol.

Let's walk through it like we're in the ER and this is happening right now.

Okay.

Step one, stop the shaking immediately.

You need a fast -acting benzodiazepine.

The text says IV diazepam or bivalorazepam.

You push that first.

Okay.

The benzo is in.

The visible seizure stops.

Are we done?

Can we relax?

No, absolutely not.

Remember, the benzo wears off in minutes.

The seizure will come right back if you don't do something else.

So step two is to load them with a long -acting suppression drug.

Farifinitoin is the standard here or phosphinitoin.

So the benzo puts out the fire and the finitoin builds the firewall to keep it from coming back.

That's the perfect analogy.

Exactly.

But what if it keeps going?

What if the benzo didn't work or the finitoin isn't working fast enough?

Then you escalate.

Step three, according to the text, can be drugs like midazolam or propofol.

You are now moving into the realm of general anesthesia.

You are sedating the patient heavily.

And if that fails, the patient is still seizing.

Step four is the last resort.

High -dose barbiturates like phenobarbital.

You are essentially inducing a medical coma to try and force the brain's electrical activity to shut down and reset.

And the whole time this is happening, what is the nurse's number one priority?

Airway, airway, airway.

You are pumping this patient full of powerful CNS depressants, benzos, finitoin, barbiturates.

They will stop breathing.

You have to be right there ready to intubate and put them on a ventilator.

That is incredibly intense, but that's the reality of the job.

It is.

It absolutely is.

Let's bring this all home now with section seven, the nursing process.

We've talked about the drugs, but how do we care for the human being taking them?

Let's start with assessment.

Okay, so recognizing cues.

You start with the history.

You need to ask about herbs, over -the -counter drugs, alcohol use, all things that can interact.

Then you look at the labs.

You need a baseline for liver function, your AST, ALT, and kidney function, your BUN and creatinine, and text makes a point to check urine output, setting a benchmark of at least 1 ,500 mL per day.

If they aren't peeing, they aren't clearing the drug.

Okay, now for interventions.

What actions do we take?

Well, seizure precautions are standard for any patient at risk.

Pad the side rails.

Keep the bed in the lowest position.

Have oxygen and suction ready at the bedside.

But specifically for the drugs, monitor the CBC.

You're watching for those blood disgraces we talked about?

Right.

If you see the platelets or the white blood cell count starting to drop, you need to hold that drug and call the provider immediately.

And also monitor nutrition phenytoin is notorious for causing nausea and anorexia.

Patient teaching.

This is where the nurse makes the biggest long -term impact on safety.

What are the non -negotiable rules?

Rule number one is adherence.

Take the medication at the same time every single day.

These drugs have narrow windows.

Missing a single dose can lower the blood level enough to trigger a seizure.

And never ever stop cold turkey.

Never.

That is the single surest way to trigger status epilepticus.

It must be tapered off under medical supervision.

What about the gums?

How do we teach them to manage that?

For the gingival hyperplasia, you teach them meticulous oral hygiene.

Use a soft bristled toothbrush.

Floss gently but regularly.

And see a dentist for checkups much more frequently than the average person.

Good hygiene can significantly minimize that overgrowth.

Safety teaching.

No driving.

Especially when first starting the drug or after a dose change.

They will be drowsy.

And legally, most states have mandatory seizure -free periods before a person can drive.

And teach them to wear a medic alert bracelet.

If they collapse in public, the EMTs need to know they have epilepsy, so they don't just assume it's a sugar crash or a drug overdose.

The text mentions a weird but harmless urine side effect.

Yes, and you have to warn them so they don't panic.

Their urine may turn a pinkish red or reddish brown color.

It looks like blood, but it's just a harmless metabolite of the drug.

But what symptoms are not harmless?

What should they report immediately?

If they get a sore throat, a fever, or start bruising easily, that's not just a cold.

That could be a sign of a granulocytosis.

They need to report it.

And if they get a rash, any rash at all, report it immediately.

It could be the start of Stevens -Johnson syndrome.

And for our diabetic patients on phenytoin.

Monitor your glucose closely.

It will likely be higher.

They might need to work with their endocrinologist to adjust their insulin or other diabetic medications.

One specific practical note on liquid meds, the suspensions.

Shake it.

You have to teach them to shake the bottle vigorously.

If you don't shake it, the heavy drug particles settle at the bottom.

The first few doses are mostly just flavored water, offering no seizure protection.

Then, when they get to the bottom of the bottle, it's a highly concentrated sludge and they get a toxic dose.

Finally, evaluation.

How do we know if our plan is working?

It's a two -part question you're always asking.

One, are the seizures controlled?

And two, are the side effects manageable and not life -threatening?

We also have to constantly watch for signs of toxicity.

And what does a phenytoin overdose look like in a patient?

It looks a lot like a drunk person.

The text mentions nystagmus.

Their eyes will be darting back and forth.

And Paxio, which is a staggering, uncoordinated walk, their speech will be slurred.

If you see that, you need to check their drug level.

If it progresses, they become hypotensive, their pupils become unresponsive, and they can slip into a coma.

Before we wrap up, let's do a quick rapid fire on table 19 .2.

These are some of the newer drugs or ones we didn't do a deep dive on, but students definitely need to recognize the names.

Let's do it.

It's an anti -seizure drug for partial seizures, but honestly you'll see it used way more often for neuropathic pain, like with diabetic neuropathy.

A very effective drug, but it carries a black box warning for that potentially life -threatening rash Stevens -Johnson syndrome.

You'll see this one, brand name Kepra, a lot in clinicals.

It has fewer drug interactions than phenytoin, which is great, but you have to watch for significant behavioral changes.

Psychosis, rage, anxiety.

Also used to prevent migraines.

Its big side effect is cognitive slowing patients have nicknamed it Dopamax, because it can cause memory impairment, and it can also cause metabolic acidosis.

And there are others listed, zonosamide, tiagabine, felbamate, but the core principles remain the same.

Depress the CNS, watch the liver and kidneys, and above all, keep the patients safe.

That's it, exactly.

The core principles apply to all of them.

Okay, we have covered a massive amount of very dense ground.

Let's head to the outro.

If our listeners take away only three things from this deep dive, what should they be?

The big three.

Number one, respect the prototype.

Phenytoin is effective, but it is dangerous.

Know the 5E rules, like the back of your hand, saline only, slow push, watch for purple glove, and understand the protein binding logic, especially for your high -risk patients.

Number two, the therapeutic range is law.

It's not a guideline, 10 to 20 mil Cgml for Phenytoin.

It is the compass by which you steer the ship of treatment.

Know it, live it, check it.

And number three.

Number three, patient teaching saves lives.

It's not just about giving the pill, it's about empowering the patient.

Teaching them not to stop abruptly, to take care of their gums, to recognize a dangerous rash, and how to navigate huge life events like pregnancy as safely as possible.

So what does this all mean?

I guess at the end of the day, it means that when you are managing a patient with epilepsy, you, the nurse, are the bridge.

You are constantly balancing that electrical storm in their brain against the chemical suppression we're using to treat it.

You are ensuring that in our effort to quiet the brain, we don't accidentally silence the person.

That's a beautiful way to put it.

It's such a delicate balance.

And the nurse is truly the one holding the scales.

Thank you so much for joining us on this deep dive into Chapter 19.

It's heavy material, but it matters so much.

It matters every single day on every single unit.

This has been the Last Minute Lecture Team signing off.

Good luck with your studies.

Keep those sodium channels regulated and stay curious.

Stay safe out there, everyone.